[HTML][HTML] Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based …
J Stomper, JC Rotondo, G Greve, M Lübbert - Leukemia, 2021 - nature.com
Aberrant DNA methylation plays a pivotal role in tumor development and progression. DNA
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
[PDF][PDF] Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based …
J Stomper, JC Rotondo, G Greve, M Lübbert - Leukemia, 2021 - iris.unife.it
Aberrant DNA methylation plays a pivotal role in tumor development and progression. DNA
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based …
J Stomper, JC Rotondo, G Greve, M Lubbert - LEUKEMIA, 2021 - sfera.unife.it
Aberrant DNA methylation plays a pivotal role in tumor development and progression. DNA
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based …
J Stomper, JC Rotondo, G Greve, M Lübbert - Leukemia, 2021 - pubmed.ncbi.nlm.nih.gov
Aberrant DNA methylation plays a pivotal role in tumor development and progression. DNA
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
[PDF][PDF] Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based …
J Stomper, JC Rotondo, G Greve, M Lübbert - 2021 - researchgate.net
Aberrant DNA methylation plays a pivotal role in tumor development and progression. DNA
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
[HTML][HTML] Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based …
J Stomper, JC Rotondo, G Greve, M Lübbert - Leukemia, 2021 - ncbi.nlm.nih.gov
Aberrant DNA methylation plays a pivotal role in tumor development and progression. DNA
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based …
J Stomper, JC Rotondo, G Greve, M Lübbert - Leukemia, 2021 - europepmc.org
Aberrant DNA methylation plays a pivotal role in tumor development and progression. DNA
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based …
J Stomper, JC Rotondo, G Greve, M Lübbert - Leukemia, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Aberrant DNA methylation plays a pivotal role
in tumor development and progression. DNA hypomethylating agents (HMA) constitute a …
in tumor development and progression. DNA hypomethylating agents (HMA) constitute a …
[PDF][PDF] Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based …
J Stomper, JC Rotondo, G Greve, M Lübbert - Leukemia, 2021 - sfera.unife.it
Aberrant DNA methylation plays a pivotal role in tumor development and progression. DNA
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
[PDF][PDF] Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based …
J Stomper, JC Rotondo, G Greve, M Lübbert - Leukemia, 2021 - iris.unife.it
Aberrant DNA methylation plays a pivotal role in tumor development and progression. DNA
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …
hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA …